141 related articles for article (PubMed ID: 23831704)
1. High sensitive assay employing column switching chromatography to enable simultaneous quantification of an amide prodrug of gemcitabine (LY2334737), gemcitabine, and its metabolite dFdU in human plasma by LC-MS/MS.
Wickremsinhe ER; Lee LB; Schmalz CA; Torchia J; Ruterbories KJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():117-22. PubMed ID: 23831704
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of gemcitabine prodrug, gemcitabine and its major metabolite 2', 2'-difluorodeoxyuridine in rat plasma by UFLC-MS/MS.
Sun Y; Zhen L; Peng Y; Wang J; Fei F; Aa L; Jiang W; Pei X; Lu L; Liu J; Wang G; Hao K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():4-13. PubMed ID: 29558739
[TBL] [Abstract][Full Text] [Related]
3. Development of a sensitive and selective LC-MS/MS method for simultaneous determination of gemcitabine and 2,2-difluoro-2-deoxyuridine in human plasma.
Bowen C; Wang S; Licea-Perez H
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):2123-9. PubMed ID: 19546035
[TBL] [Abstract][Full Text] [Related]
4. LC-MS/MS method for quantitation of gemcitabine and its metabolite 2',2'-difluoro-2'-deoxyuridine in mouse plasma and brain tissue: Application to a preclinical pharmacokinetic study.
Zhong B; Gibson EG; Davis A; Roussel MF; Stewart CF
J Pharm Biomed Anal; 2021 May; 198():114025. PubMed ID: 33744463
[TBL] [Abstract][Full Text] [Related]
5. Preanalytical Stability of Gemcitabine and its Metabolite 2', 2'-Difluoro-2'-Deoxyuridine in Whole Blood-Assessed by Liquid Chromatography Tandem Mass Spectrometry.
Bjånes T; Kamčeva T; Eide T; Riedel B; Schjøtt J; Svardal A
J Pharm Sci; 2015 Dec; 104(12):4427-4432. PubMed ID: 26372902
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry.
Marangon E; Sala F; Caffo O; Galligioni E; D'Incalci M; Zucchetti M
J Mass Spectrom; 2008 Feb; 43(2):216-23. PubMed ID: 17941128
[TBL] [Abstract][Full Text] [Related]
7. Determination of gemcitabine and its metabolite in extracellular fluid of rat brain tumor by ultra performance liquid chromatography-tandem mass spectrometry using microdialysis sampling after intralesional chemotherapy.
Sun Y; Tang D; Chen H; Zhang F; Fan B; Zhang B; Fang S; Lu Q; Wei Y; Yin J; Yin X
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():10-9. PubMed ID: 23396113
[TBL] [Abstract][Full Text] [Related]
8. Ultra-sensitive LC-MS/MS method for the quantification of gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma for a microdose clinical trial.
van Nuland M; Hillebrand MJX; Rosing H; Burgers JA; Schellens JHM; Beijnen JH
J Pharm Biomed Anal; 2018 Mar; 151():25-31. PubMed ID: 29294409
[TBL] [Abstract][Full Text] [Related]
9. Sensitive liquid chromatography mass spectrometry (LC-MS) assay reveals novel insights on DNA methylation and incorporation of gemcitabine, its metabolite difluorodeoxyuridine, deoxyuridine, and RX-3117 into DNA.
Honeywell RJ; Sarkisjan D; Kathmann I; Kristensen MH; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):652-662. PubMed ID: 27906622
[TBL] [Abstract][Full Text] [Related]
10. Measurement of the anticancer agent gemcitabine and its deaminated metabolite at low concentrations in human plasma by liquid chromatography-mass spectrometry.
Xu Y; Keith B; Grem JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 802(2):263-70. PubMed ID: 15018786
[TBL] [Abstract][Full Text] [Related]
11. Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides.
Derissen EJB; Huitema ADR; Rosing H; Schellens JHM; Beijnen JH
Br J Clin Pharmacol; 2018 Jun; 84(6):1279-1289. PubMed ID: 29451684
[TBL] [Abstract][Full Text] [Related]
12. A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopy.
Bapiro TE; Richards FM; Goldgraben MA; Olive KP; Madhu B; Frese KK; Cook N; Jacobetz MA; Smith DM; Tuveson DA; Griffiths JR; Jodrell DI
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1243-53. PubMed ID: 21431415
[TBL] [Abstract][Full Text] [Related]
13. Determination of gemcitabine and its metabolite in human plasma using high-pressure liquid chromatography coupled with a diode array detector.
Lin NM; Zeng S; Ma SL; Fan Y; Zhong HJ; Fang L
Acta Pharmacol Sin; 2004 Dec; 25(12):1584-9. PubMed ID: 15569401
[TBL] [Abstract][Full Text] [Related]
14. Sensitive analysis and pharmacokinetic study of a novel gemcitabine carbamate prodrug and its active metabolite gemcitabine in rats using LC-ESI-MS/MS.
Zhou Y; Chang Q; Wang W; Zhang X; Zhou F; Sun J; Wang G; Peng Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1083():249-257. PubMed ID: 29554521
[TBL] [Abstract][Full Text] [Related]
15. Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry.
Vainchtein LD; Rosing H; Thijssen B; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2007; 21(14):2312-22. PubMed ID: 17577879
[TBL] [Abstract][Full Text] [Related]
16. Validated procedure for simultaneous trace level determination of the anti-cancer agent gemcitabine and its metabolite in human urine by high-performance liquid chromatography with tandem mass spectrometry.
Sottani C; Zucchetti M; Zaffaroni M; Bettinelli M; Minoia C
Rapid Commun Mass Spectrom; 2004; 18(10):1017-23. PubMed ID: 15150823
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of gemcitabine and its primary metabolite in dogs after intravenous infusion.
Freise KJ; Martín-Jiménez T
J Vet Pharmacol Ther; 2006 Apr; 29(2):147-52. PubMed ID: 16515669
[TBL] [Abstract][Full Text] [Related]
18. Determination of the phosphorylated metabolites of gemcitabine and of difluorodeoxyuridine by LCMSMS.
Honeywell RJ; Giovannetti E; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1203-13. PubMed ID: 22132976
[TBL] [Abstract][Full Text] [Related]
19. Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells.
Pratt SE; Durland-Busbice S; Shepard RL; Heinz-Taheny K; Iversen PW; Dantzig AH
Clin Cancer Res; 2013 Mar; 19(5):1159-68. PubMed ID: 23325581
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascites.
Delauter BJ; Ramanathan RK; Egorin MJ; Stover LL; Zuhowski EG; Plunkett W; Zamboni WC
Pharmacotherapy; 2000 Oct; 20(10):1204-7. PubMed ID: 11034044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
